Cancer

HER2-targeted drugs (trastuzumab)

Antibodies and kinase inhibitors aimed at the HER2 receptor, overexpressed in about a fifth of breast cancers; trastuzumab greatly improves survival in HER2-positive disease, with a risk of reversible heart dysfunction.

Mechanism of action

Molecular targets

Drugs in HER2-targeted drugs (trastuzumab)

Monoclonal antibodies

Antibody–drug conjugate

Tyrosine kinase inhibitors

Therapeutic uses

Diseases it treats

Adverse effects

Contraindications by condition

Other cautions and interactions

Connected topics

Written from

Educational reference. Not medical advice, diagnosis or treatment.